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Objectives: This study characterized temporal changes in the infrarenal aortic aneurysm neck in patients with small,
untreated abdominal aortic aneurysms (AAA).
Methods: Patients with infrarenal AAA who had contrast-enhanced computed tomography (CT) scans separated by >6
months were identified and their images reviewed. Infrarenal neck diameter and length were measured along with
aneurysm diameter. Comparisons between the interval CT scans were made and analysis of factors affecting neck changes
performed.
Results: Sixty patients met inclusion criteria with an imaging interval of 3.8 years (median, 3.4 years; range, 0.75-9.6
years). During the interval, there was an increase in proximal and distal neck diameters of 1.1 mm (SD, 2.2) (0.28 mm/y)
and 1.0 mm (SD, 3.0) (0.26 mm/y), respectively. During the same interval, the neck length decreased by 4 mm (SD, 11)
(1 mm/y). A neck length of <15 mm was present in 10 patients (17%) at the initial imaging. Four of the remaining 50
patients experienced an interval decrease in neck length to <15 mm, all of whom had initial lengths of 15 to 20 mm.
Medications had no association with changes in neck morphology; however, diabetes correlated with a slower rate of neck
shortening (P  .001).
Conclusion: The natural history of the aneurysm neck is one of expansion and shortening that will not affect most patients
under surveillance. Patients with marginal neck lengths (range, 15-20 mm) at the initial imaging are more likely to
experience loss of neck length that may negatively affect endovascular suitability. ( J Vasc Surg 2010;51:1111-5.)Criteria for intervention on AAAs are based on natural
history studies, many of which predated the routine use of
computed tomography (CT) scanning.1-6 Because rupture
risk and death is most associated with maximum transverse
diameter, natural history studies have focused on this spe-
cific aneurysm measurement. In addition, maximum diam-
eter is quickly, effectively, and reproducibly measured with
ultrasound imaging, which has furthered an understanding
of changes in this particular aneurysm measurement over
time. In aggregate, natural history studies demonstrate that
the increase in maximum aneurysm diameter is 2 to 3 mm
annually.4,7-9
In contrast, much less is known about the change in
measurement of the infrarenal AAA neck over extended
periods. This portion of the healthy aorta below the renal
arteries and above the beginning of the aneurysm is more
difficult to accurately and consistently measure with ultra-
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ture. Thus, temporal measurements of the length and di-
ameter of the aneurysm neck have not been emphasized
during ultrasound imaging, and the natural history of this
aortic segment is unknown.
With a prevailing focus on endovascular aneurysm re-
pair (EVAR), an improved if not thorough understanding
of the natural history of this aortic segment is desirable.
Although some studies have documented the morphologic
behavior of AAA neck after both open and endovascular
treatment, few have used serial CT imaging to document
changes in the length and diameter of the untreated aneu-
rysm neck for an extended period.10 The objective of this
study was to determine the changes in length and diameter
of the infrarenal aortic neck in untreated AAAs using serial
contrast CT imaging.
METHODS
Institutional Review Board approval was obtained for
this investigation according to guidelines for the clinical
study of human subjects.
Patient cohort and CT imaging. Patients with in-
frarenal AAAs (3.5 cm and 5.6 cm) who had contrast-
enhancedCT imaging for any reason from2000 to 2007were
identified. The medical records and radiographic imaging
of 89 individuals who met the inclusion criteria were retro-
spectively reviewed. CT imaging of patients in this study
was not necessarily part of a formal aneurysm surveillance
program. Although the indication for some of the CT
imaging was related to the presence of an aneurysm in some
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primary focus of this study. Aneurysm surveillance at the
institution where the study was conducted instead was
based on duplex ultrasound imaging, with CT reserved for
patients in whom the aneurysm diameter approached or
reached 5 cm. To enable observation of change in aneu-
rysm neck morphology over time, the two scans separated
by the greatest interval of time were selected for measure-
ments, and any additional CT imaging that occurred be-
tween these scans was not evaluated.
The study excluded patients with CT scans separated by
6 months, or those who underwent open or EVAR aortic
interventions before the second CT scan or who had had an
intervention for ruptured AAA. Also excluded were pa-
tients with concomitant thoracic, thoracoabdominal, or
juxtarenal aneurysms. A total of 60 patients met inclusion
criteria for the study. Once the population was identified,
the initial CT andmost recent CT images were re-evaluated
according to study protocol. No additional radiographic
imaging was conducted as a result of this study.
Measurementmethods. CT images were reviewed on
Centricity software (General Electric Healthcare, Allen-
dale, NJ) by one of five members of the vascular surgery
division. Evaluators were blinded to the name, sequence,
and timing of the aortic imaging. Specific measurements
included in the analysis were recorded in millimeters and
were labeled as follows:
1. greatest transverse aneurysm diameter;
2. proximal neck diameter, defined as the first CT image
below the most caudal, main renal artery;
3. distal neck diameter, defined as the last CT image before
the appearance of the aneurysm; and
4. neck length, defined as the distance in millimeters be-
tween the images where the proximal and distal neck
diameter measurements were made.
Axial measurements were performed using a uniform
“outer wall to outer wall” measurement to assess diameter.
Measurements of aortic neck parameters were based on
pre-established and validated criteria for EVAR eligibility,
and the determination of endovascular neck suitability was
made using these same validated standards.11
Clinical variables. Clinical variables collected from
the electronic medical record included gender, presence or
absence of diabetes, smoking status, and body mass index
(BMI) in kg/m2. All clinical data were gathered1 year of
the initial CT scan. Use of the following medications was
recorded at the initial CT scan: 3-hydroxy-3-methylglutaryl
coenzyme A reductase (statins), -receptor antagonists (ie,
-blockers), angiotensin-converting enzyme (ACE) inhib-
itors, and angiotensin receptor blockers.
Patients were defined as having diabetes if there was a
documented diagnosis of diabetes, a hemoglobin A1C level
7, or they were using prescription medication for diabe-
tes. Again, this determination wasmade with regard to each
patient’s initial CT scan. Patients were stratified to one of
four groups for analysis based on definitions from the
Centers for Disease Control (CDC): underweight (BMI18.5), normal (BMI, 18.5-24.9), overweight (BMI, 25-
29.9), or obese (BMI 30).12
Statistical analysis. All data collected for diameter or
neck length changes were continuous in nature. Mean
variables are expressed with the standard deviation (SD),
and mean changes were compared between the initial and
follow-up CT scans using paired t testing. The patient
population was dichotomized into two groups by a trans-
verse AAA diameter of 4 cm and 4 cm. Four centime-
ters was selected because it falls between the smallest diam-
eter at which an aneurysm is recognized (3 cm) and the
diameter at which intervention is often contemplated (5 cm).
Analysis between these two groups was byWilcoxon testing
using differences between the median values to express
variance. Values of P  .05 were considered statistically
significant.
RESULTS
Demographics and imaging intervals. The 60 indi-
viduals (53 men, 7 women) who met the inclusion criteria
were a mean age of 72 years. Mean separation between the
contrast CT examinations was 3.8 years (median, 3.4;
range, 0.75-9.6 years). The distribution of time in years
between the two CT studies for patients in the cohort is
shown in the Fig. Of note, the imaging intervals in 17
patients (nearly 25%) of the cohort were5 years. Diabetes
was positively identified in 19 (32%). Medications in the
cohort consisted of statins in 47 (78%), -blockers in 43
(72%), and ACE inhibitors in 39 (65%).
Maximum aneurysm diameter. The average maxi-
mum aneurysm diameter at the initial CT scan was 39 mm
(SD, 6.8; range, 26-56), which increased to 45 mm (SD,
7.9; range 28-58) at the second imaging study. The cumu-
lative increase in maximum aneurysm diameter over the
Fig. Distribution of time in years between computed tomography
scans.interval scanning period was 6 mm (P  .001), yielding an
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maximum aneurysm diameter change between men (5.9
mm) and women (7.0 mm; P  .65).
Patients were dichotomized into two groups according
to the initial AAA maximum diameter of 4 cm (group 1,
n 34) and4 cm (group 2, n 26) at the initial contrast
CT scan. The average aneurysm expansion was 1.25 mm/y
(interquartile range [IQR]1, 0.34; IQR3, 1.9 mm/y) in
group 1 and 1.72 mm/y (IQR1, 1; IQR3, 3.01 mm/y) in
group 2 (P  .09).
Changes in aneurysm neck diameter. During the
interval CT scan period, the cumulative increases in proxi-
mal and distal neck diameters were 1.1 mm (SD, 2.2 mm)
and 1.0 mm (SD, 3.0 mm), respectively. Expressed per-
year, these expansion rates are 0.28 mm and 0.26 mm for
the proximal and distal aneurysm neck, respectively.
Changes in aneurysm neck length. The average ini-
tial length of the aortic neck for the cohort was 32mm (SD,
17; range, 3-90 mm), and the average neck length at the
second or interval CT image was 28 mm (SD, 14.8 mm;
range, 0-58 mm), a decrease of 4 mm (SD, 11 mm) in
aneurysm neck length (P .008), which corresponds to an
annual decrease of 1 mm. Individuals in group 1 (original
AAA diameter 4 cm) demonstrated a rate of neck length
decrease of 0.61 mm/y (IQR1,2.2; IQR3, 0.46 mm/y)
compared with group 2 (original AAA 4 cm), who dem-
onstrated shortening of only 0.29 mm/y (IQR1, 1.1;
IQR3, 0.9 mm/y; P  .15). There was no difference in
neck length change between men (3.8 mm) and women
(4.8 mm; P .82) during the interval CT scanning time.
Marginal neck morphology. Ten patients (17%) in
the overall cohort had an aortic neck of 15 mm, and
another 11 patients (18%) had a neck length of 15 to 20
mm.Only 4 of 50 individuals (8%)with starting neck length
of 15 mm experienced a decrease in length to 15 mm
during the intervening scans. These four had a marginal
starting neck length of 15 to 20 mm. The average interval
time between initial and final CT scans for these four
patients was 45 months. No patients in the cohort who
started with a neck length of 20 mm experienced a
decrease in length to 15 mm.
Clinical variables. During the CT scan interval, the
13 patients in the study who were active smokers had an
aneurysm diameter expansion of 8.5 mm vs 5.5 mm in
nonsmokers (P  .14). The change in neck length in
patients who were smokers was not different than in pa-
tients who were nonsmokers (P  .69). Although medica-
tions had no association with neck shortening, diabetes
mellitus correlated with slower rate of neck shortening (P
.001; Table).
DISCUSSION
Findings from this study demonstrate that the natural
history of the aortic aneurysm neck is one of definable
diameter expansion and length shortening. Specifically,
aneurysm neck diameter increases at an average 0.26 mm
and length decreases an average of 1 mm each year during
surveillance. This study further demonstrates that duringperiods of observation, a small but finite percentage of
patients (8%) will experience a decrease in length to 15
mm, but those with marginal neck lengths of 15 to 20 mm
have increased chance (36%) of shortening 15 mm. To-
gether, these results provide new insight into a specific
aortic segment that is of great importance when an obser-
vation of small aneurysms is being contemplated.
To date, AAA screening and surveillance rely on ultra-
sound imaging to diagnose aneurysms and identify changes
in maximum aortic diameter.13 Because this measurement
relates directly to AAA rupture risk and because it is basic to
obtain, it has been the focus of ultrasound scanning proto-
cols. In contrast, aortic neck morphology is difficult to
quantify with ultrasound imaging, and because it is not
directly related to AAA rupture, it has been relatively ig-
nored by this imaging technique. Subsequently, there are
limited data on the morphologic changes of the infrarenal
aortic neck during periods of surveillance.
The paucity of ultrasound data necessitates that CT
imaging be queried for further insight into the behavior of
this aortic segment over time. Although CT imaging does
provide the needed detail to characterize the aortic neck,5,6
a surprisingly limited number of patients with AAA have
two or more quality contrast-enhanced CT scans separated
by a significant period of time, a trend that may be further
accentuated in an era in which routine CT imaging is
discouraged because of concerns of contrast nephropathy.
Yau et al10 were among the first to study interval CT
imaging for insight into changes in aneurysm suitability for
EVAR. In a report from theUniversity of Texas Southwest-
ern, the average decrease in neck length was 6 mm during a
24-month CT imaging interval (3 mm/y). Despite a rate of
neck decrease that was nearly three times that in the current
study, Yau et al10 reported no loss in EVAR suitability
during their relatively short imaging interval.
Results from this study confirm and extend the findings
from Yau et al, providing information from a different
cohort of patients with almost twice the CT imaging time
interval. In addition, we believe our study is the first to
attempt to account for the potential effect of specific med-
ications on aneurysm neck changes. Although no associa-
tion between medication use and neck behavior was found,
Table. Clinical variable and influence on neck length
change
Variable
Yes
(change mm)
No
(change mm)
Unknown
(change mm) P
Statin 47 (4.4) 13 (2.2) 0 .53
-blocker 43 (4.3) 17 (3.0) 0 .69
ACE 39 (2.9) 21 (5.9) 0 .31
Diabetes 19 (7.1) 39 (2.4) 2 .001
Normal Overweight Obese
BMI, kg/m2 16 (5.3) 18 (3.3) 15 (1.3) .62
ACE, Angiotensin-converting enzyme; BMI, body mass index.three-quarters of the cohort in the current study were
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cernible differences unlikely. Other reports have substanti-
ated a protective effect of statins on decreasing aneurysm
expansion rates, and it is not unreasonable to consider that
a similar protective effect may exist for the more proximal,
nonaneurysmal aortic neck.14,15 Although data from this
study do not support this theory, only 60 patients were
included in our study population, and larger cohorts would
be needed to effectively evaluate any protective effects.
Results from this study confirm previous studies that
define an average maximal aneurysm diameter increase of 2
mm/y.4,7,8 This finding validates the measurement tech-
niques of this study and supports the defined changes found
in aortic neck length and diameter. In addition, the higher
rate of maximum aneurysm diameter expansion found in
aneurysms 4 cm vs 4 cm is consistent with previous
work reporting a higher expansion rate in larger aneu-
rysms.7
The increase in the maximal transverse diameter re-
mains the key tenet in guiding AAA repair, but the predom-
inance of EVAR in today’s practice increases the impor-
tance of changes in surrounding aortic topography. This
study confirms that small but finite changes in the proximal
and distal aortic neck diameters can be anticipated over
time. For most patients, the rate of neck shortening and
expansion defined in this study will not influence future
endovascular suitability. However, endovascular suitability
may be diminished or lost in a small subset of patients with
an initial marginal neck length because of the natural his-
tory of this segment of the aorta.
In this cohort, 10 patients had neck lengths of15mm
on initial CT imaging and would not have been EVAR
candidates based on conservative treatment practices and
most instructions for use. At the time of the initial CT
imaging, an additional 11 patients had marginal neck
lengths of 15 to 20mm.Of these, four (36%) demonstrated
neck shortening to15 mm during the follow-up imaging
interval, which averaged 45 months, and the lengthy inter-
val might have resulted in the high rate of shortening 15
mm. For the entire cohort, loss of neck suitability occurred
in 8% of patients who started with a neck length of15mm
at the initial CT imaging. Together, these findings provide
surgeons information with which to act on when managing
patients with small AAAs under surveillance. Treatment
decisions will ultimately still be guided by maximum aneu-
rysm diameter. However, this understanding of the natural
history of the aortic neck will allow providers to reassure
most patients with small AAAs and pursue a more vigilant
approach in others, which may include medical optimiza-
tion, more frequent surveillance, or even earlier surgical
intervention.
This study has limitations to consider. Specifically, cur-
rent CT imaging and accompanying software is superior to
that available 10 years ago. This cohort contains a portion
of patients with follow-up intervals requiring comparisons
between current and older CT imaging. In many of the
dated CT studies, three-dimensional reconstructions with
centerline measurements were not available, and in suchinstances, table length measurements were used for evalu-
ation. Although less precise than today’s CT imaging,
previous CT scans are still the most accurate modality by
which to establish baseline or past aneurysm neck morphol-
ogy. Furthermore, including older or baseline CT scans
allowed for an extended imaging interval to evaluate
change in the aorta and aortic neck. Although an ideal
study to assess changes in aneurysm neck morphology over
time might include prospective modern contrast CT imag-
ing of small AAAs at regular intervals, this is neither feasible
nor ethical. And as such, a retrospective study of available
CT imaging such as this study represents a valid and prac-
tical alternative by which to gain insight into this important
topic.
An additional limitation stems from the lack of infor-
mation about morphologic characteristics such as calcifica-
tion, thrombus burden, and angulation, which were not
assessed, as well as extended lengths such as distance from
the lowest renal artery to the aortic bifurcation and internal
iliac arteries. Similarly, changes in angulation and extended
lengths were not pursued because many of the CT scans at
the initial evaluation were performed without centerline
software, thus limiting the accurate quantification and
comparison of these extended lengths and angles.
Finally, the relatively small size of this cohort limits the
ability of this study to make some statistical comparisons.
To our surprise, the number of patients able to be studied
was limited by the relatively small number of patients out of
all those with known AAAs at our institution who had
undergone two quality, contrast-enhanced CT scans sepa-
rated by a significant interval of time.
CONCLUSIONS
Despite these limitations, the findings of this study
provide new and valuable insight into the natural history of
the aortic neck of AAAs using a cohort of patients with
interval CT imaging, the likes of which appear to be rela-
tively unique at this time.
As aneurysms expand, aortic neck length is reduced by
1 mm/y, whereas increases in neck diameter are negligible
(0.25 mm/y). The natural history of the aortic neck will
not significantly affect most patients with small AAAs un-
dergoing surveillance. However, a small percentage of pa-
tients (8%) with an appropriate neck length at the initial
imaging will experience a reduction in length that may
preclude EVAR in later years. The effect of medical opti-
mization on the natural history of the aortic neck is un-
known but deserves further study.
AUTHOR CONTRIBUTIONS
Conception and design: BP, TR, WJ, SG, GB, WC
Analysis and interpretation: BP, TR, WJ, SG, GB, WC
Data collection: BP, WJ, SG, GB
Writing the article: BP, TR, SG, GB, WC
Critical revision of the article: BP, TR, WJ, SG, GB, WC
Final approval of the article: BP, TR, SG, WC
Statistical analysis: BP, TR, SG, GB, WC
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 5 Propper et al 1115Obtained funding: BP, TR, GB, WC
Overall responsibility: WC
REFERENCES
1. Shapiro E. Aneurysm of the abdominal aorta. The prognosis of the
condition untreated. Cal Med 1958;87:155-57.
2. Bernstein EF, Chan EL. Abdominal aortic aneurysm in high-risk pa-
tients. Outcome of selective management based on size and expansion
rate. Ann Surg 1984;200:255-62.
3. Cronenwett JL, Murphy TF, Zelenock GB, Whitehouse WM Jr, Lin-
denauer SM, Graham LM, et al. Actuarial analysis of variables associated
with rupture of small abdominal aortic aneurysms. Surgery 1985;98:
472-83.
4. Nevitt MP, Ballard DJ, Hallett JW Jr. Prognosis of abdominal aortic
aneurysms. A population based study. N Engl JMed 1989;321:1040-2.
5. Limet R, Sakalihassan N, Albert A. Determination of the expansion rate
and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg
1991;14:540-8.
6. Vega de Céniga M, Gómez R, Estallo L, de la Fuente N, Viviens B,
Barba A. Analysis of expansion patterns in 4-4.9 cm abdominal aortic
aneurysms. Ann Vasc Surg 2008;22:37-44.
7. Lederle FA. The natural history of abdominal aortic aneurysms. Acta
Chir Belg 2009;109:7-12.
8. Scholosser FJ, TangelderMJ, VerghagenHJ, van derHeijdenGJ,Muhs
BE, van der Graaf Y, et al. Growth predictors and prognosis of small
abdominal aortic aneurysms. J Vasc Surg 2008;47:1127-33.9. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher
CW, et al. Immediate repair compared with surveillance of small ab-
dominal aortic aneurysms. N Eng J Med 2002;346:1437-44.
10. Yau FS, Rosero EB, Clagett P, Valentine RJ,Modrall GJ, Arko FR, et al.
Surveillance of small aortic aneurysms does not alter anatomic suitability
for endovascular repair. J Vasc Surg 2007;45:96-100.
11. Chaikof EL, Fillinger MF, Matsumura JS, Rutherford RB, White GH,
Blankensteijn JD, et al. Identifying and grading factors that modify the
outcome of endovascular aortic aneurysm repair. J Vasc Surg 2002;35:
1061-6.
12. Centers for Disease Control and Prevention. Healthy weight—it’s not a
diet, it’s a lifestyle! www.cdc.gov/healthyweight. Accessed Dec 14,
2010.
13. US Department of Health and Human Services. Agency for Healthcare
Research and Quality. U.S. Preventive Services Task Force (USPSTF)
screening for abdominal aortic aneurysm recommendation statement.
http://www.ahrq.gov/clinic/uspstf05/aaascr/aaars.htm. Accessed Dec
14, 2010.
14. Schouten O, van Laanen J, Boersma E, Vidakovic R, Feringa HH,
Dunkelgrun M, et al. Statins are associated with a reduced infrarenal
abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006;
32:22-26.
15. Propranolol Aneurysm Trial Investigators. Propranolol for small ab-
dominal aortic aneurysms: results of a randomized controlled trial. J
Vasc Surg 2002;35:72-9.Submitted Oct 23, 2009; accepted Dec 15, 2009.
